103 related articles for article (PubMed ID: 16286981)
1. Preliminary study concerning the cytoscreen system importance (liquid based cytology) in gynecologic cytology.
Popescu CF; Bădulescu A; Bădulescu F; Cotarcea S; Găvănescu M
Rom J Morphol Embryol; 2005; 46(1):23-7. PubMed ID: 16286981
[TBL] [Abstract][Full Text] [Related]
2. [Applicative aspects of liquid-based cytology in cervical cancer screening].
Liverani M; De Paola F; Danesi S; Fedriga R; Dalbuoni V; Agnoletti R; Amadori AR; Mirra F; Bonoli W; Saragoni L
Pathologica; 2006 Dec; 98(6):629-34. PubMed ID: 17285839
[TBL] [Abstract][Full Text] [Related]
3. DCS liquid-based system is more effective than conventional smears to diagnosis of cervical lesions: study in high-risk population with biopsy-based confirmation.
Longatto Filho A; Pereira SM; Di Loreto C; Utagawa ML; Makabe S; Sakamoto Maeda MY; Marques JA; Santoro CL; Castelo A
Gynecol Oncol; 2005 May; 97(2):497-500. PubMed ID: 15863150
[TBL] [Abstract][Full Text] [Related]
4. Liquid-based cervical cytology.
Klinkhamer PJ; Meerding WJ; Rosier PF; Hanselaar AG
Cancer; 2003 Oct; 99(5):263-71. PubMed ID: 14579292
[TBL] [Abstract][Full Text] [Related]
5. Comparison of conventional Papanicolaou smears and fluid-based, thin-layer cytology with colposcopic biopsy control in central Italy: a consecutive sampling study of 461 cases.
Rahimi S; Carnovale-Scalzo C; Marani C; Renzi C; Malvasi A; Votano S
Diagn Cytopathol; 2009 Jan; 37(1):1-3. PubMed ID: 18973131
[TBL] [Abstract][Full Text] [Related]
6. Anorectal cytology as a screening tool for anal squamous lesions: cytologic, anoscopic, and histologic correlation.
Friedlander MA; Stier E; Lin O
Cancer; 2004 Feb; 102(1):19-26. PubMed ID: 14968414
[TBL] [Abstract][Full Text] [Related]
7. Gain of the 3q26 region in cervicovaginal liquid-based pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma.
Caraway NP; Khanna A; Dawlett M; Guo M; Guo N; Lin E; Katz RL
Gynecol Oncol; 2008 Jul; 110(1):37-42. PubMed ID: 18433848
[TBL] [Abstract][Full Text] [Related]
8. Cytologic diagnosis of atypical squamous cells of undetermined significance in perimenopausal and postmenopausal women: lessons learned from human Papillomavirus DNA testing.
Johnston EI; Logani S
Cancer; 2007 Jun; 111(3):160-5. PubMed ID: 17506090
[TBL] [Abstract][Full Text] [Related]
9. Triage of women with ASCUS and LSIL cytology: use of qualitative assessment of p16INK4a positive cells to identify patients with high-grade cervical intraepithelial neoplasia.
Wentzensen N; Bergeron C; Cas F; Vinokurova S; von Knebel Doeberitz M
Cancer; 2007 Feb; 111(1):58-66. PubMed ID: 17186505
[TBL] [Abstract][Full Text] [Related]
10. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.
Jordan J; Arbyn M; Martin-Hirsch P; Schenck U; Baldauf JJ; Da Silva D; Anttila A; Nieminen P; Prendiville W
Cytopathology; 2008 Dec; 19(6):342-54. PubMed ID: 19040546
[TBL] [Abstract][Full Text] [Related]
11. [Two cytological methods for screening for cervical cancer].
Kirschner B; Simonsen K; Junge J
Ugeskr Laeger; 2008 May; 170(22):1933-7. PubMed ID: 18513478
[TBL] [Abstract][Full Text] [Related]
12. DNA ploidy compared with human papilloma virus testing (Hybrid Capture II) and conventional cervical cytology as a primary screening test for cervical high-grade lesions and cancer in 1555 patients with biopsy confirmation.
Guillaud M; Benedet JL; Cantor SB; Staerkel G; Follen M; MacAulay C
Cancer; 2006 Jul; 107(2):309-18. PubMed ID: 16773634
[TBL] [Abstract][Full Text] [Related]
13. Rapid prescreening of Papanicolaou smears: a practical and efficient quality control strategy.
Djemli A; Khetani K; Auger M
Cancer; 2006 Feb; 108(1):21-6. PubMed ID: 16302251
[TBL] [Abstract][Full Text] [Related]
14. The Bethesda system for the reporting of cervical/vaginal cytology.
Oren A; Fernandes J
J Am Osteopath Assoc; 1991 May; 91(5):476-9. PubMed ID: 2061103
[TBL] [Abstract][Full Text] [Related]
15. Comparison of conventional Papanicolaou smear and SurePath liquid-based cytology in the Copenhagen population screening programme for cervical cancer.
Kirschner B; Simonsen K; Junge J
Cytopathology; 2006 Aug; 17(4):187-94. PubMed ID: 16879266
[TBL] [Abstract][Full Text] [Related]
16. Significance of atypia in conventional Papanicolaou smears and liquid-based cytology: a follow-up study.
Schledermann D; Ejersbo D; Hoelund B
Cytopathology; 2004 Jun; 15(3):148-53. PubMed ID: 15165271
[TBL] [Abstract][Full Text] [Related]
17. Past experience of SUUB's Pathology Department in classic based cervico-vaginal cytology.
Lăzăroiu AM; Comănescu M; Moldovan V; Secară D; Cîrstoiu M; Sajin M; Stoian M; Anton G
Rom J Morphol Embryol; 2009; 50(4):619-23. PubMed ID: 19942956
[TBL] [Abstract][Full Text] [Related]
18. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
Zhao C; Austin RM
Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of p16INK4a in cervical lesion of premenopausal and postmenopausal women.
Bolanca IK; Ciglar S
Coll Antropol; 2007 Apr; 31 Suppl 2():107-11. PubMed ID: 17600938
[TBL] [Abstract][Full Text] [Related]
20. Impact of the more restrictive definition of atypical squamous cells introduced by the 2001 Bethesda System on the sensitivity and specificity of the Papanicolaou test: a 5-year follow-up study of Papanicolaou tests originally interpreted as ASCUS, reclassified according to Bethesda 2001 criteria.
Thrall MJ; Pambuccian SE; Stelow EB; McKeon DM; Miller L; Savik K; Gulbahce HE
Cancer; 2008 Jun; 114(3):171-9. PubMed ID: 18454461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
